Skip to main content
OpenTrials

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,647 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy

NCT00000807

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • K Norris Cancer Hosp / Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States
  • San Francisco Gen Hosp San Francisco, California, United States
View all 20 locations
View Trial Details
Completed

The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients

NCT00000861

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Community Consortium of San Francisco San Francisco, California, United States
  • Denver CPCRA / Denver Public Hlth Denver, Colorado, United States
  • Veterans Administration Med Ctr / Regional AIDS Program Washington D.C., District of Columbia, United States
  • AIDS Research Consortium of Atlanta Atlanta, Georgia, United States
View all 14 locations
View Trial Details
Completed

A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection

NCT00000812

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • University of Minnesota, ACTU Minneapolis, Minnesota, United States
  • Memorial Sloan-Kettering Cancer Ctr. New York, United States
  • Unc Aids Crs Chapel Hill, North Carolina, United States
View Trial Details
Completed

A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection

NCT00000823

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • San Francisco Gen Hosp San Francisco, California, United States
  • Univ of Colorado Health Sciences Ctr Denver, Colorado, United States
  • Univ of Miami School of Medicine Miami, Florida, United States
View all 22 locations
View Trial Details
Completed

Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis

NCT00000794

Conditions
Abscess, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +29 more
Locations
  • USC CRS Los Angeles, California, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
  • Queens Med. Ctr. Honolulu, Hawaii, United States
  • Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu, Hawaii, United States
View all 16 locations
View Trial Details
Completed

A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease

NCT00000880

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • San Francisco Gen Hosp San Francisco, California, United States
  • Univ of Colorado Health Sciences Ctr Denver, Colorado, United States
  • Northwestern Univ Med School Chicago, Illinois, United States
  • Rush Presbyterian - Saint Luke's Med Ctr Chicago, Illinois, United States
View Trial Details
Completed

A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients

NCT00000863

Conditions
AIDS-Related Opportunistic Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +23 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • Queens Med. Ctr. Honolulu, Hawaii, United States
  • Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu, Hawaii, United States
  • Northwestern University CRS Chicago, Illinois, United States
View Trial Details
Completed

A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons

NCT00000743

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU New Orleans, Louisiana, United States
  • Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States
  • Unc Aids Crs Chapel Hill, North Carolina, United States
View Trial Details

Related conditions